168 related articles for article (PubMed ID: 166117)
1. Antiviral activity of an adenosine deaminase inhibitor: decreased replication of herpes simplex virus.
Williams BB; Lerner AM
J Infect Dis; 1975 Jun; 131(6):673-7. PubMed ID: 166117
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity in the rabbit cornea of adenine arabinoside, Ara-A 5' monophosphate, and hypoxanthine arabinoside; and interactions with adenosine deaminase inhibitor.
Falcon MG; Jones BR
J Gen Virol; 1977 Jul; 36(1):199-202. PubMed ID: 196039
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of arabinosyladenine and arabinosylhypoxanthine in herpes simplex virus-infected KB cells: selective inhibition of viral deoxyribonucleic acid synthesis in the presence of an adenosine deaminase inhibitor.
Schwartz PM; Shipman C; Drach JC
Antimicrob Agents Chemother; 1976 Jul; 10(1):64-74. PubMed ID: 185947
[TBL] [Abstract][Full Text] [Related]
4. Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
North TW; Cohen SS
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4684-8. PubMed ID: 216993
[TBL] [Abstract][Full Text] [Related]
5. Adenine arabinoside inhibition of adenovirus replication enhanced by an adenosine deaminase inhibitor.
Wigand R
J Med Virol; 1979; 4(1):59-65. PubMed ID: 119038
[TBL] [Abstract][Full Text] [Related]
6. Effect of a novel adenosine deaminase inhibitor (co-vidarabine, co-V) upon the antiviral activity in vitro and in vivo of vidarabine (Vira-Atm) for DNA virus replication.
Sloan BJ; Kielty JK; Miller FA
Ann N Y Acad Sci; 1977 Mar; 284():60-80. PubMed ID: 212990
[TBL] [Abstract][Full Text] [Related]
7. Antiherpesvirus activity in human sera and urines after administration of adenine arabinoside: in vitro and in vivo synergy of adenine arabinoside and arabinosylhypoxanthine in combination.
Champney KJ; Lauter CB; Bailey EJ; Lerner AM
J Clin Invest; 1978 Dec; 62(6):1142-53. PubMed ID: 219024
[TBL] [Abstract][Full Text] [Related]
8. Erythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in mice.
Shannon WM; Arnett G; Schabel FM; North TW; Cohen SS
Antimicrob Agents Chemother; 1980 Oct; 18(4):598-603. PubMed ID: 6255863
[TBL] [Abstract][Full Text] [Related]
9. Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor.
Bryson Y; Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
Antimicrob Agents Chemother; 1974 Jul; 6(1):98-101. PubMed ID: 15828177
[TBL] [Abstract][Full Text] [Related]
10. Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus.
Connor JD; Sweetman L; Carey S; Stuckey MA; Buchanan R
Antimicrob Agents Chemother; 1974 Nov; 6(5):630-6. PubMed ID: 15825318
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of arabinosyladenine in herpes simplex virus-infected and uninfected cells. Correlation with inhibition of DNA synthesis and role in antiviral selectivity.
Schwartz PM; Novack J; Shipman C; Drach JC
Biochem Pharmacol; 1984 Aug; 33(15):2431-8. PubMed ID: 6087827
[TBL] [Abstract][Full Text] [Related]
12. Deoxyadenosine antagonism of the antiviral activity of 9-beta-D-arabinofuranosyladenine and 9-beta-D-arabinofuranosylhypoxanthine.
Smith SH; Shipman C; Drach JC
Cancer Res; 1978 Jul; 38(7):1916-21. PubMed ID: 207416
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of adenosine deaminase by co-vidarabine and its effect on the metabolic disposition of adenine arabinoside (vidarabine).
Borondy PE; Chang T; Maschewske E; Glazko AJ
Ann N Y Acad Sci; 1977 Mar; 284():9-20. PubMed ID: 280160
[No Abstract] [Full Text] [Related]
14. Adechlorin, a new adenosine deaminase inhibitor containing chlorine production, isolation and properties.
Omura S; Imamura N; Kuga H; Ishikawa H; Yamazaki Y; Okano K; Kimura K; Takahashi Y; Tanaka H
J Antibiot (Tokyo); 1985 Aug; 38(8):1008-15. PubMed ID: 3840153
[TBL] [Abstract][Full Text] [Related]
15. The biochemical pharmacology of (2'-R)-chloropentostatin, a novel inhibitor of adenosine deaminase.
Jackson RC; Leopold WR; Ross DA
Adv Enzyme Regul; 1986; 25():125-39. PubMed ID: 2433905
[TBL] [Abstract][Full Text] [Related]
16. Adenosine deaminase inhibitors. Synthesis and biological activity of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Franchetti P; Grifantini M; Vittori S; Lupidi G; Riva F; Bordoni T; Geroni C; Verini MA
J Med Chem; 1988 Feb; 31(2):390-3. PubMed ID: 3339608
[TBL] [Abstract][Full Text] [Related]
17. Studies on inhibition of adenosine deaminase by isocoformycin in vitro and in vivo.
Shimazaki M; Kumada Y; Takeuchi T; Umezawa H; Watanabe K
J Antibiot (Tokyo); 1979 Jun; 32(6):654-8. PubMed ID: 468739
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory and lethal concentrations of 9-beta-D-arabinofuranosyladenine and its hypoxanthine-derivative versus herpes simplex virus, type 1.
Williams BB; Bailey EJ; Lerner AM
J Lab Clin Med; 1977 Apr; 89(4):687-91. PubMed ID: 191546
[TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity of herpes simplex virus types 1 and 2 to human interferon: antiviral effects of interferon plus 9-beta-D-arabinofuranosyladenine.
Lerner AM; Bailey EJ
J Infect Dis; 1976 Oct; 134(4):400-4. PubMed ID: 185303
[TBL] [Abstract][Full Text] [Related]
20. Effect of adenosine deaminase inhibitors on the apparent rate of phosphorylation of deoxyadenosine.
Deibel MR; Coleman MS; Hutton JJ
Biochem Med; 1981 Jun; 25(3):288-97. PubMed ID: 6973972
[No Abstract] [Full Text] [Related]
[Next] [New Search]